| Q44514177 | A novel methodology for AV and VV delay optimization in CRT: results from a randomized pilot clinical trial. |
| Q44915368 | Acute left hemothorax as a late complication of an active-fixation pacemaker lead. |
| Q33160734 | An increased endothelial-independent vasodilation is the hallmark of the neurally mediated syncope. |
| Q36849242 | Appropriateness of ECG Holter requests in an outpatient service: a prospective study |
| Q90716436 | Arrhythmias and sleep apnea: physiopathologic link and clinical implications |
| Q50248095 | Arrhythmogenic right-ventricular cardiomyopathy and cardiac microvascular disease: a rare association or a possible link? |
| Q44460481 | Clinical and electrical performance of currently available MRI-safe pacing systems. Do all devices perform in the same way? |
| Q43962624 | Clinical and procedural outcome of patients implanted with a quadripolar left ventricular lead: early results of a prospective multicenter study. |
| Q33155151 | Coronary spasm: a case of transient ST elevation and syncopal ventricular tachycardia without angina |
| Q43711928 | Device monitoring of heart failure in cardiac resynchronization therapy device recipients: a single-center experience with a novel multivector impedance monitoring system. |
| Q87272656 | Early detection of high voltage lead failure with an unusual and unexpected device alert |
| Q44585577 | Effectiveness of ibutilide in cardioversion of persistent atrial fibrillation in patients with dual chamber stimulation |
| Q36216807 | Electrical cardioversion of atrial fibrillation: different methods for a safe and effective technique |
| Q81508562 | Electrocardiographic markers of structural heart disease and predictors of death in 2332 unselected patients undergoing outpatient Holter recording |
| Q86910320 | Endothelial dysfunction is a marker of systemic response to the cardiac resynchronization therapy in heart failure |
| Q38449411 | Esophageal electrical cardioversion of atrial fibrillation: when esophagus gives a help to cardiologists |
| Q30581704 | Evaluating MRI-compatible pacemakers: patient data now paves the way to widespread clinical application? |
| Q37495738 | Exploring the Potential Role of Catheter Ablation in Patients with Asymptomatic Atrial Fibrillation: Should We Move away from Symptom Relief? |
| Q50981128 | Feasibility and safety of a simplified draping method for pacing procedures. |
| Q90915451 | Feasibility of automated detection of sleep apnea using implantable pacemakers and defibrillators: a comparison with simultaneous polysomnography recording |
| Q87035718 | First clinical experience with the new four-pole standard connector for high-voltage ICD leads. Early results of a multicenter comparison with conventional implant outcomes |
| Q110902014 | Flecainide How and When: A Practical Guide in Supraventricular Arrhythmias |
| Q34794812 | Hospitalization rates and associated cost analysis of cardiac resynchronization therapy with an implantable defibrillator and quadripolar vs. bipolar left ventricular leads: a comparative effectiveness study |
| Q92417973 | ICD-measured heart sounds and their correlation with echocardiographic indexes of systolic and diastolic function |
| Q50990819 | Impact of continuous intracardiac ST-segment monitoring on mid-term outcomes of ICD-implanted patients with coronary artery disease. Early results of a prospective comparison with conventional ICD outcomes. |
| Q84441064 | Impact of previous myocardial infarction on outcomes of CRT patients implanted with a quadripolar left ventricular lead. Results from a multicentric prospective study |
| Q41600865 | Improved implant and postoperative lead performance in CRT-D patients implanted with a quadripolar left ventricular lead. A 6-month follow-up analysis from a multicenter prospective comparative study |
| Q45357095 | Left ventricular pacing with a new quadripolar transvenous lead for CRT: Early results of a prospective comparison with conventional implant outcomes |
| Q51636445 | Long-term monitoring of respiratory rate in patients with heart failure: the Multiparametric Heart Failure Evaluation in Implantable Cardioverter-Defibrillator Patients (MULTITUDE-HF) study. |
| Q38392442 | Multipoint pacing via a quadripolar left-ventricular lead: preliminary results from the Italian registry on multipoint left-ventricular pacing in cardiac resynchronization therapy (IRON-MPP). |
| Q38827596 | Novel devices to monitor heart failure and minimize hospitalizations |
| Q38240915 | Novel perspectives on arrhythmia-induced cardiomyopathy: pathophysiology, clinical manifestations and an update on invasive management strategies |
| Q48590563 | Outpatient oesophageal-precordial electrical cardioversion of atrial fibrillation: an effective and safe technique to restore sinus rhythm |
| Q41819738 | Oversensing of an unexpected atrial flutter. A new tool to improve detection of supraventricular arrhythmias in subcutaneous implantable cardioverter-defibrillators |
| Q41890823 | Partners in crime in the setting of recurring cardiac arrest |
| Q79433444 | Physiologic pacing for atrial fibrillation prevention in sinus node disease: long-term results |
| Q54288209 | Predictive value of fragmented QRS in primary prevention implantable cardioverter defibrillator recipients with left ventricular dysfunction. |
| Q55517476 | Preliminary experience with a novel Multisensor algorithm for heart failure monitoring: The HeartLogic index. |
| Q64282995 | Preliminary experience with the multisensor HeartLogic algorithm for heart failure monitoring: a retrospective case series report |
| Q34389483 | Present concepts in management of atrial fibrillation: From drug therapy to ablation |
| Q46927040 | Prevalence and clinical relevance of marked repolarization abnormalities in a large series of apparently healthy adults |
| Q92027959 | Prospective evaluation of the multisensor HeartLogic algorithm for heart failure monitoring |
| Q44464554 | Relations between monophasic action potential duration and refractoriness after cardioversion of persistent atrial fibrillation: results in wash-out and amiodarone-treated patients. |
| Q45346499 | Safety and efficacy of a new magnetic resonance imaging-compatible pacing system: early results of a prospective comparison with conventional dual-chamber implant outcomes |
| Q90416692 | Single- and multi-site pacing strategies for optimal cardiac resynchronization therapy: impact on device longevity and therapy cost |
| Q33168005 | Sudden Death After Transcatheter Aortic Valve Implantation. Are Bradyarrhythmias Always The Cause? |
| Q44413637 | Systematic fluoroscopic and electrical assessment of implantable cardioverter-defibrillator patients implanted with silicone-polyurethane copolymer (Optim™) coated leads |
| Q38648458 | The role of implantable devices to treat atrial fibrillation |
| Q73629398 | Transesophageal low-energy cardioversion of atrial fibrillation without fluoroscopy outside the electrophysiology laboratory |
| Q46857457 | Transthoracic versus transesophageal cardioversion of atrial fibrillation under light sedation: a prospective randomized trial |
| Q84789007 | Without a quadripolar left ventricular lead you don't succeed: a challenging case of phrenic nerve stimulation |
| Q47695605 | Work burden with remote monitoring of implantable cardioverter defibrillator: is it time for reimbursement policies? |
| Q50656743 | [Electromagnetic interference in the current era of cardiac implantable electronic devices designed for magnetic resonance environment]. |
| Q46008255 | [Remote monitoring of atrial fibrillation and heart failure]. |
| Q82362778 | n-3 polyunsaturated fatty acids for the prevention of arrhythmia recurrence after electrical cardioversion of chronic persistent atrial fibrillation: a randomized, double-blind, multicentre study |